ANDA 77174, held by Hospira. Foscarnet Sodium.
As of Nov 16, 2026, ANDA 77174 (Foscarnet Sodium), held by Hospira, was first approved by FDA on May 31, 2005, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 31, 2005 | Original application | Approved |
| Foscarnet Sodium6GM/250ML (24MG/ML) · solution;intravenous | Foscarnet Sodium | Discontinued |
| Foscarnet Sodium12GM/500ML (24MG/ML) · solution;intravenous | Foscarnet Sodium | Discontinued |
| May 9, 2008 | Supplement 4Labeling | Approved | None posted |
| May 31, 2005 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters